Michael J. Fox, a long time proponent of stem cell research as a possible key to finding the cure for Parkinson’s disease, said there have been “problems along the way,” in an interview with ABC’s Diane Sawyer. “Stem cells are an avenue of research that weve pursued and continue to pursue but its part of a broad portfolio of things that we look at. … Continue reading
State Awards Stem Cell Research Funding
More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted May 17, 2012 Courtesy of MDBIZNes By Nick Sohr, Managing Editor, MDBIZNews Maryland approved state funding for 40 researchers studying human stem cells and their applications in treating a wide range of diseases and other medical conditions. The awards, approved Thursday by the Maryland Technology Development Corporation, will be paid from the Maryland Stem Cell Research Fund’s $12.4 million budget for fiscal 2012. … Continue reading
Osiris Wins Canadian Approval for First Stem-Cell Therapy
By Meg Tirrell – 2012-05-17T20:35:40Z Osiris Therapeutics Inc. (OSIR) said it won the worlds first approval for a stem-cell drug, gaining clearance in Canada to sell Prochymal for a disease that can attack patients who received bone-marrow transplants… Continue reading
World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal
COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics Inc. (NASDAQ:OSIR – News) announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children… Continue reading
Industry Consultant Gregory Bonfiglio Joins California Stem Cell Board of Directors
IRVINE, Calif.–(BUSINESS WIRE)– California Stem Cell, Inc. (CSC) announced today that well-known stem cell & regenerative medicine industry veteran Gregory A. … Continue reading
Maryland Stem Cell Research Commission Funds 40 New Proposals in FY 2012
More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted May 17, 2012 Awards to advance regenerative medicine address diverse, debilitating diseases and conditions COLUMBIA, Md. – The Maryland Stem Cell Research Commissionhas completed its review of the 179 applications received in response to its three FY 2012 Requests for Applications (RFAs)… Continue reading
Human Embryonic Stem Cells Used To Grow Bone Tissue
May 15, 2012 A New York Stem Cell Foundation (NYSCF) scientist has shown in new research that human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential medical applications. Dr. Darja Marolt, an investigator at the NYSCF, is the lead author of the study, which was published this week in the online edition of the Proceedings of the National Academy of Sciences (PNAS)… Continue reading
Stem cell debate could flare in Neb. regents race
A long-standing dispute over embryonic stem cell research is likely to resurface during the general election race for candidates of the University of Nebraska Board of Regents. Regent hopefuls in at least one district differ on the use of research, which has divided the board in past years and caught the attention of an influential Nebraska anti-abortion group. … Continue reading
International Stem Cell Corp Announces First Quarter 2012 Financial Results and Business Highlights
CARLSBAD, Calif.–(BUSINESS WIRE)– International Stem Cell Corporation (OTCBB: ISCO.OB – News) (www.internationalstemcell.com) today announced financial results for the three months ended March 31, 2012. Three Months ended March 31, 2012 Consolidated net revenues for the three months ended March 31, 2012 were $1.08 million compared to $1.52 million in the corresponding period a year ago. … Continue reading
Scientists Discover Clues to Muscle Stem Cell Functions
Study reveals a potential key to new treatment strategies for Muscular Dystrophy Newswise May 14, 2012 – Oakland, Calif. A study conducted by Childrens Hospital & Research Center Oakland scientists identifies how skeletal muscle stem cells respond to muscle injury and may be stimulated to improve muscle repair in Duchenne Muscular Dystrophy, a severe inherited disease of muscle that causes weakness, disability and, ultimately, heart and respiratory failure. The study, led by Julie D… Continue reading
